AstraZeneca PLC ZEGA-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 5:03 PM CEST
63.60quote price arrow up+2.00 (+3.25%)
52 week range
46.20 - 64.80
Loading...
  • Open62.00
  • Day High63.60
  • Day Low62.00
  • Prev Close61.40
  • 52 Week High64.80
  • 52 Week High Date04/08/22
  • 52 Week Low46.20
  • 52 Week Low Date09/20/21

Key Stats

  • Market Cap188,440.69M
  • Shares Out1,549.45M
  • 10 Day Average Volume618.09
  • Dividend1.26
  • Dividend Yield1.98%
  • Beta-
  • YTD % Change24.71

KEY STATS

  • Open62.00
  • Day High63.60
  • Day Low62.00
  • Prev Close61.40
  • 52 Week High64.80
  • 52 Week High Date04/08/22
  • 52 Week Low46.20
  • 52 Week Low Date09/20/21
  • Market Cap188,440.69M
  • Shares Out1,549.45M
  • 10 Day Average Volume618.09
  • Dividend1.26
  • Dividend Yield1.98%
  • Beta-
  • YTD % Change24.71

RATIOS/PROFITABILITY

  • EPS (TTM)-0.30
  • P/E (TTM)-212.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/24/2022
  • Div Amount0.985
  • Split Date-
  • Split Factor-

Related Video

VIDEO9:3109:31
Zoetis, Pepsi, and Dutch Bros are some of the stocks: Pro Market Movers June 14

Profile

MORE
AstraZeneca PLC is a patient-focused pharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines. The Company is focused on various therapy areas, such as Oncology; BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism (CVRM) and Respiratory & Immunology (R&I)), and Rare Disease. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development....
Leif Johansson
Independent Non-Executive Chairman of the Board
Pascal Soriot
Chief Executive Officer, Executive Director
Aradhana Sarin M.D.
Chief Financial Officer, Executive Director
Ruud Dobber Ph.D.
Executive Vice President - BioPharmaceuticals Business Unit
Menelas Pangalos
Executive Vice President - Research and Development BioPharmaceuticals
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom